Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a)
Open Access
- 14 April 1998
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (8) , 4544-4549
- https://doi.org/10.1073/pnas.95.8.4544
Abstract
We have generated mice with markedly elevated plasma levels of human low density lipoprotein (LDL) and reduced plasma levels of high density lipoprotein. These mice have no functional LDL receptors [ LDLR −/− ] and express a human apolipoprotein B-100 (apoB) transgene [ Tg(apoB +/+ )] with or without an apo(a) transgene [ Tg(apoa +/− )]. Twenty animals (10 males and 10 females) of each of the following four genotypes were maintained on a chow diet: ( i ) LDLR −/− , ( ii ) LDLR −/− ; Tg(apoa +/− ), (iii ) LDLR −/− ; Tg(apoB +/+ ), and ( iv ) LDLR −/− ; Tg(apoB +/+ );Tg(apo +/− ). The mice were killed at 6 mo, and the percent area of the aortic intimal surface that stained positive for neutral lipid was quantified. Mean percent areas of lipid staining were not significantly different between the LDLR −/− and LDLR −/− ; Tg(apoa +/− ) mice (1.0 ± 0.2% vs. 1.4 ± 0.3%). However, the LDLR −/− ; Tg(apoB +/+ ) mice had ≈15-fold greater mean lesion area than the LDLR −/− mice. No significant difference was found in percent lesion area in the LDLR −/− ; Tg(apoB +/+ ) mice whether or not they expressed apo(a) [18.5 ± 2.5%, without lipoprotein(a), Lp(a), vs. 16.0 ± 1.7%, with Lp(a)]. Histochemical analyses of the sections from the proximal aorta of LDLR −/− ; Tg(apoB +/+ ) mice revealed large, complex, lipid-laden atherosclerotic lesions that stained intensely with human apoB-100 antibodies. In mice expressing Lp(a), large amounts of apo(a) protein colocalized with apoB-100 in the lesions. We conclude that LDLR −/− ; Tg(apoB +/+ ) mice exhibit accelerated atherosclerosis on a chow diet and thus provide an excellent animal model in which to study atherosclerosis. We found no evidence that apo(a) increased atherosclerosis in this animal model.Keywords
This publication has 30 references indexed in Scilit:
- Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice.Journal of Clinical Investigation, 1997
- Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.Journal of Clinical Investigation, 1997
- Feedback Mechanism of Focal Vascular Lesion Formation in Transgenic Apolipoprotein(a) MiceJournal of Biological Chemistry, 1996
- Overexpression of Human Apolipoprotein B-100 in Transgenic Rabbits Results in Increased Levels of LDL and Decreased Levels of HDLArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.Journal of Clinical Investigation, 1995
- Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a).Journal of Clinical Investigation, 1993
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cellsPublished by Elsevier ,1992
- Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986